Cargando…
Circulating Tumour DNA Sequencing Identifies a Genetic Resistance-Gap in Colorectal Cancers with Acquired Resistance to EGFR-Antibodies and Chemotherapy
SIMPLE SUMMARY: Recent studies have shown the potential of next generation sequencing (NGS) for the identification of genetic variants in tumour DNA that has been released into the bloodstream (ctDNA). However, such variants are often rare in the sample and error correction is required to filter out...
Autores principales: | Knebel, Franciele H., Barber, Louise J., Newey, Alice, Kleftogiannis, Dimitrios, Woolston, Andrew, Griffiths, Beatrice, Fenwick, Kerry, Bettoni, Fabiana, Ribeiro, Maurício Fernando Silva Almeida, da Fonseca, Leonardo, Costa, Frederico, Capareli, Fernanda Cunha, Hoff, Paulo M., Sabbaga, Jorge, Camargo, Anamaria A., Gerlinger, Marco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7764102/ https://www.ncbi.nlm.nih.gov/pubmed/33322618 http://dx.doi.org/10.3390/cancers12123736 |
Ejemplares similares
-
Circulating Tumor DNA Detection in the Management of Anti-EGFR Therapy for Advanced Colorectal Cancer
por: Knebel, Franciele H., et al.
Publicado: (2019) -
Mutational signatures impact the evolution of anti-EGFR antibody resistance in colorectal cancer
por: Woolston, Andrew, et al.
Publicado: (2021) -
Impressive response to dabrafenib, trametinib, and osimertinib in a metastatic EGFR-mutant/BRAF V600E lung adenocarcinoma patient
por: Ribeiro, Maurício Fernando Silva Almeida, et al.
Publicado: (2021) -
Author Correction: Extreme intratumour heterogeneity and driver evolution in mismatch repair deficient gastro-oesophageal cancer
por: von Loga, Katharina, et al.
Publicado: (2020) -
Extreme intratumour heterogeneity and driver evolution in mismatch repair deficient gastro-oesophageal cancer
por: von Loga, Katharina, et al.
Publicado: (2020)